Presentation Information
[O-46-5]Long-term Efficacy of Efgartigimod PH20 SC in CIDP: Interim Results from the ADHERE+ Study
Ryo Yamasaki1, Jeffrel Allen2, Jie Lin3, Mark Stetter4, Jeffrey Guptill5,6, Kelly Gwathmey7, Geoffrey Istas6, Arne De Roeck6, Giuseppe Lauria8, Luis Querol9, Niraja Suresh10, Chafic Karam11, Thomas Skripuletz12, Simon Rinaldi13, Andoni Echaniz - Laguna14, Benjamin Van Hoorick6, Pieter Van Doorn15, Richard Lewis16, Satoshi Kuwabara17 (1.Kyushu University, Japan, 2.University of Minnesota, USA, 3.Fudan University, China, 4.University of Essen, Germany, 5.Duke University, USA, 6.argenx, Belgium, 7.Virginia Commonwealth University, USA, 8.University of Milan, Italy, 9.Universitat Autònoma de Barcelona, Spain, 10.Lakeland Regional Health, USA, 11.University of Pennsylvania, USA, 12.Hannover Medical School, Germany, 13.University of Oxford, UK, 14.Bicêtre Hospital, France, 15.Erasmus University, Netherlands, 16.Cedars-Sinai Medical Center, USA, 17.Chiba University, Neurology, Japan)